Yıl: 2023 Cilt: 65 Sayı: 5 Sayfa Aralığı: 832 - 844 Metin Dili: İngilizce DOI: 10.24953/turkjped.2022.573 İndeks Tarihi: 15-11-2023

Possible effects of N-acetylcysteine in autism spectrum disorders: major clinical aspects, eating behaviors, and sleeping habits

Öz:
Background. N-acetylcysteine (NAC) is a promising agent for reducing irritability and hyperactivity and enhancing social responsiveness in children with autism spectrum disorders (ASD). This study aims to examine the effects of NAC on cardinal symptoms, eating, and sleeping habits in preschool children with autism. Methods. The medical records of ASD patients were investigated retrospectively. 37 children with ASD who regularly received oral NAC in two divided doses per day (400-600 mg/day) for 8 weeks were included as the study group. The control group consisted of 21 children with ASD who were recommended NAC but never used it. The initial and second assessment scores after 8 weeks of regular use of the NAC group and control group on the Childhood Autism Rating Scale (CARS), Aberrant Behavior Checklist (ABC), Children Eating Behavior Questionnaire (CEBQ), and the Sleep Habits Questionnaire (CSHQ) were compared. Results. Our findings suggested that oral NAC alleviated the intensity of cardinal autistic symptoms in areas of social withdrawal, interpersonal relationships, body use, listening response, and verbal communication. Corresponding problem behaviors such as irritability, stereotypic behavior, and hyperactivity were reduced. It was determined that there was no difference between the two groups in terms of eating behaviors and sleeping habits. Conclusions. According to the results, NAC alleviated the severity of cardinal symptoms and reduced problem behaviors in autism. Additional trials with more systematic planning, controlling for confounding effects, and long-term follow-up should be provided in future studies.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Association AP. Diagnostic and statistical manual of mental disorders (DSM-5®). American Psychiatric Pub; 2013.
  • 2. Xu G, Strathearn L, Liu B, et al. Prevalence and treatment patterns of autism spectrum disorder in the United States, 2016. JAMA Pediatr 2019; 173: 153-159. https://doi.org/10.1001/jamapediatrics.2018.4208
  • 3. Hallmayer J, Cleveland S, Torres A, et al. Genetic heritability and shared environmental factors among twin pairs with autism. Arch Gen Psychiatry 2011; 68: 1095-1102. https://doi.org/10.1001/ archgenpsychiatry.2011.76
  • 4. Cheroni C, Caporale N, Testa G. Autism spectrum disorder at the crossroad between genes and environment: contributions, convergences, and interactions in ASD developmental pathophysiology. Mol Autism 2020; 11: 69. https://doi.org/10.1186/ s13229-020-00370-1
  • 5. Islam MT. Oxidative stress and mitochondrial dysfunction-linked neurodegenerative disorders. Neurol Res 2017; 39: 73-82. https://doi.org/10.1080/ 01616412.2016.1251711
  • 6. Cipolla CM, Lodhi IJ. Peroxisomal dysfunction in age-related diseases. Trends Endocrinol Metab 2017; 28: 297-308. https://doi.org/10.1016/j.tem.2016.12.003
  • 7. Osredkar J, Gosar D, Maček J, et al. Urinary markers of oxidative stress in children with Autism Spectrum Disorder (ASD). Antioxidants (Basel) 2019; 8: 187. https://doi.org/10.3390/antiox8060187
  • 8. Bjørklund G, Meguid NA, El-Bana MA, et al. Oxidative stress in autism spectrum disorder. Mol Neurobiol 2020; 57: 2314-2332. https://doi. org/10.1007/s12035-019-01742-2
  • 9. Yui K, Tanuma N, Yamada H, Kawasaki Y. Reduced endogenous urinary total antioxidant power and its relation of plasma antioxidant activity of superoxide dismutase in individuals with autism spectrum disorder. Int J Dev Neurosci 2017; 60: 70-77. https://doi.org/10.1016/j.ijdevneu.2016.08.003
  • 10. Marí M, Morales A, Colell A, García-Ruiz C, Fernández-Checa JC. Mitochondrial glutathione, a key survival antioxidant. Antioxid Redox Signal 2009; 11: 2685-2700. https://doi.org/10.1089/ ARS.2009.2695
  • 11. Wu G, Fang YZ, Yang S, Lupton JR, Turner ND. Glutathione metabolism and its implications for health. J Nutr 2004; 134: 489-492. https://doi. org/10.1093/jn/134.3.489
  • 12. Kern JK, Jones AM. Evidence of toxicity, oxidative stress, and neuronal insult in autism. J Toxicol Environ Health B Crit Rev 2006; 9: 485-499. https:// doi.org/10.1080/10937400600882079
  • 13. Sedlak TW, Paul BD, Parker GM, et al. The glutathione cycle shapes synaptic glutamate activity. Proc Natl Acad Sci U S A 2019; 116: 2701-2706. https://doi. org/10.1073/pnas.1817885116
  • 14. Page LA, Daly E, Schmitz N, et al. In vivo 1H-magnetic resonance spectroscopy study of amygdala-hippocampal and parietal regions in autism. Am J Psychiatry 2006; 163: 2189-2192. https:// doi.org/10.1176/appi.ajp.163.12.2189
  • 15. Chauhan A, Audhya T, Chauhan V. Brain regionspecific glutathione redox imbalance in autism. Neurochem Res 2012; 37: 1681-1689. https://doi. org/10.1007/s11064-012-0775-4
  • 16. McBean GJ. Cysteine, glutathione, and thiol redox balance in astrocytes. Antioxidants (Basel) 2017; 6: 62. https://doi.org/10.3390/antiox6030062
  • 17. Hurst GA, Shaw PB, LeMaistre CA. Laboratory and clinical evaluation of the mucolytic properties of acetylcysteine. Am Rev Respir Dis. 1967; 96(5): 962- 970.
  • 18. Aldini G, Altomare A, Baron G, et al. N-Acetylcysteine as an antioxidant and disulphide breaking agent: the reasons why. Free Radic Res 2018; 52: 751-762. https://doi.org/10.1080/10715762.2018.1468564
  • 19. Schwalfenberg GK. N-Acetylcysteine: a review of clinical usefulness (an old drug with new tricks). J Nutr Metab 2021; 2021: 9949453. https://doi. org/10.1155/2021/9949453
  • 20. Lee TM, Lee KM, Lee CY, Lee HC, Tam KW, Loh EW. Effectiveness of N-acetylcysteine in autism spectrum disorders: A meta-analysis of randomized controlled trials. Aust N Z J Psychiatry 2021; 55: 196- 206. https://doi.org/10.1177/0004867420952540
  • 21. Zhang Y, Cui W, Zhai Q, Zhang T, Wen X. N-acetylcysteine ameliorates repetitive/stereotypic behavior due to its antioxidant properties without activation of the canonical Wnt pathway in a valproic acid-induced rat model of autism. Mol Med Rep 2017; 16: 2233-2240. https://doi.org/10.3892/ mmr.2017.6787
  • 22. Chen YW, Lin HC, Ng MC, et al. Activation of mGluR2/3 underlies the effects of N-acetylcystein on amygdala-associated autism-like phenotypes in a valproate-induced rat model of autism. Front Behav Neurosci 2014; 8: 219. https://doi.org/10.3389/ fnbeh.2014.00219
  • 23. Jouett NP, Moralez G, White DW, et al. N-Acetylcysteine reduces hyperacute intermittent hypoxia-induced sympathoexcitation in human subjects. Exp Physiol 2016; 101: 387-396. https://doi. org/10.1113/EP085546
  • 24. Association AP. DSM-5 Autism spectrum disorder fact sheet. Arlington, VA: American Psychiatric; 2013.
  • 25. Schopler E, Reichler RJ, DeVellis RF, Daly K. Toward objective classification of childhood autism: Childhood Autism Rating Scale (CARS). J Autism Dev Disord 1980; 10: 91-103. https://doi.org/10.1007/ BF02408436
  • 26. Sucuoglu B, Oktem F, Akkok F, Gokler B. A study of the scales for the assessment of the children with autism. Psikiyatri, Psikoloji, Psikofarmakoloji (3P) 1996; 4: 116-121.
  • 27. Incekas Gassaloglu S, Baykara B, Avcil S, Demiral Y. Validity and reliability analysis of Turkish version of childhood autism rating scale. Turk Psikiyatri Derg 2016; 27: 266-274.
  • 28. Aman MG, Singh NN, Stewart AW, Field CJ. The aberrant behavior checklist: a behavior rating scale for the assessment of treatment effects. Am J Ment Defic 1985; 89: 485-491. https://doi.org/10.1037/ t10453-000
  • 29. Karabekiroglu K, Aman MG. Validity of the aberrant behavior checklist in a clinical sample of toddlers. Child Psychiatry Hum Dev 2009; 40: 99-110. https:// doi.org/10.1007/s10578-008-0108-7
  • 30. Wardle J, Guthrie CA, Sanderson S, Rapoport L. Development of the children’s eating behaviour questionnaire. J Child Psychol Psychiatry 2001; 42: 963-970. https://doi.org/10.1111/1469-7610.00792
  • 31. Yılmaz R, Esmeray H, Erkorkmaz Ü. Adaptation study of the Turkish Children’s Eating Behavior Questionnaire. Anadolu Psikiyatri Dergisi 2011; 12: 287-294.
  • 32. Owens JA, Spirito A, McGuinn M. The Children’s Sleep Habits Questionnaire (CSHQ): psychometric properties of a survey instrument for school-aged children. Sleep 2000; 23: 1043-1051. https://doi. org/10.1093/sleep/23.8.1d
  • 33. Perdahlı Fiş N, Arman A, Ay P, et al. The validity and the reliability of Turkish Version of Children’s Sleep Habits Questionnaire. Anadolu Psikiyatri Dergisi 2010; 11: 151-160.
  • 34. Hardan AY, Fung LK, Libove RA, et al. A randomized controlled pilot trial of oral N-acetylcysteine in children with autism. Biol Psychiatry 2012; 71: 956- 961. https://doi.org/10.1016/j.biopsych.2012.01.014
  • 35. Ghanizadeh A, Moghimi-Sarani E. A randomized double blind placebo controlled clinical trial of N-Acetylcysteine added to risperidone for treating autistic disorders. BMC Psychiatry 2013; 13: 196. https://doi.org/10.1186/1471-244X-13-196
  • 36. Nikoo M, Radnia H, Farokhnia M, Mohammadi MR, Akhondzadeh S. N-acetylcysteine as an adjunctive therapy to risperidone for treatment of irritability in autism: a randomized, double-blind, placebocontrolled clinical trial of efficacy and safety. Clin Neuropharmacol 2015; 38: 11-17. https://doi. org/10.1097/WNF.0000000000000063
  • 37. Wink LK, Adams R, Wang Z, et al. A randomized placebo-controlled pilot study of N-acetylcysteine in youth with autism spectrum disorder. Mol Autism 2016; 7: 26. https://doi.org/10.1186/s13229-016-0088-6
  • 38. Marí-Bauset S, Zazpe I, Mari-Sanchis A, Llopis- González A, Morales-Suárez-Varela M. Food selectivity in autism spectrum disorders: a systematic review. J Child Neurol 2014; 29: 1554-1561. https://doi.org/10.1177/0883073813498821
  • 39. Ranjan S, Nasser JA. Nutritional status of individuals with autism spectrum disorders: do we know enough? Adv Nutr 2015; 6: 397-407. https://doi. org/10.3945/an.114.007914
  • 40. Sharp WG, Berry RC, McCracken C, et al. Feeding problems and nutrient intake in children with autism spectrum disorders: a meta-analysis and comprehensive review of the literature. J Autism Dev Disord 2013; 43: 2159-2173. https://doi.org/10.1007/ s10803-013-1771-5
  • 41. Chistol LT, Bandini LG, Must A, Phillips S, Cermak SA, Curtin C. Sensory sensitivity and food selectivity in children with autism spectrum disorder. J Autism Dev Disord 2018; 48: 583-591. https://doi.org/10.1007/ s10803-017-3340-9
  • 42. Wallace GL, Richard E, Wolff A, Nadeau M, Zucker N. Increased emotional eating behaviors in children with autism: sex differences and links with dietary variety. Autism 2021; 25: 603-612. https://doi. org/10.1177/1362361320942087
  • 43. Johnson KP, Zarrinnegar P. Autism spectrum disorder and sleep. Child Adolesc Psychiatr Clin N Am 2021; 30: 195-208. https://doi.org/10.1016/j. chc.2020.08.012
  • 44. Johnson MH. Functional brain development in humans. Nat Rev Neurosci 2001; 2: 475-483. https://doi.org/10.1038/35081509
APA nalbant k, ERDEN S (2023). Possible effects of N-acetylcysteine in autism spectrum disorders: major clinical aspects, eating behaviors, and sleeping habits. , 832 - 844. 10.24953/turkjped.2022.573
Chicago nalbant kevser,ERDEN SEMİH Possible effects of N-acetylcysteine in autism spectrum disorders: major clinical aspects, eating behaviors, and sleeping habits. (2023): 832 - 844. 10.24953/turkjped.2022.573
MLA nalbant kevser,ERDEN SEMİH Possible effects of N-acetylcysteine in autism spectrum disorders: major clinical aspects, eating behaviors, and sleeping habits. , 2023, ss.832 - 844. 10.24953/turkjped.2022.573
AMA nalbant k,ERDEN S Possible effects of N-acetylcysteine in autism spectrum disorders: major clinical aspects, eating behaviors, and sleeping habits. . 2023; 832 - 844. 10.24953/turkjped.2022.573
Vancouver nalbant k,ERDEN S Possible effects of N-acetylcysteine in autism spectrum disorders: major clinical aspects, eating behaviors, and sleeping habits. . 2023; 832 - 844. 10.24953/turkjped.2022.573
IEEE nalbant k,ERDEN S "Possible effects of N-acetylcysteine in autism spectrum disorders: major clinical aspects, eating behaviors, and sleeping habits." , ss.832 - 844, 2023. 10.24953/turkjped.2022.573
ISNAD nalbant, kevser - ERDEN, SEMİH. "Possible effects of N-acetylcysteine in autism spectrum disorders: major clinical aspects, eating behaviors, and sleeping habits". (2023), 832-844. https://doi.org/10.24953/turkjped.2022.573
APA nalbant k, ERDEN S (2023). Possible effects of N-acetylcysteine in autism spectrum disorders: major clinical aspects, eating behaviors, and sleeping habits. Turkish Journal of Pediatrics, 65(5), 832 - 844. 10.24953/turkjped.2022.573
Chicago nalbant kevser,ERDEN SEMİH Possible effects of N-acetylcysteine in autism spectrum disorders: major clinical aspects, eating behaviors, and sleeping habits. Turkish Journal of Pediatrics 65, no.5 (2023): 832 - 844. 10.24953/turkjped.2022.573
MLA nalbant kevser,ERDEN SEMİH Possible effects of N-acetylcysteine in autism spectrum disorders: major clinical aspects, eating behaviors, and sleeping habits. Turkish Journal of Pediatrics, vol.65, no.5, 2023, ss.832 - 844. 10.24953/turkjped.2022.573
AMA nalbant k,ERDEN S Possible effects of N-acetylcysteine in autism spectrum disorders: major clinical aspects, eating behaviors, and sleeping habits. Turkish Journal of Pediatrics. 2023; 65(5): 832 - 844. 10.24953/turkjped.2022.573
Vancouver nalbant k,ERDEN S Possible effects of N-acetylcysteine in autism spectrum disorders: major clinical aspects, eating behaviors, and sleeping habits. Turkish Journal of Pediatrics. 2023; 65(5): 832 - 844. 10.24953/turkjped.2022.573
IEEE nalbant k,ERDEN S "Possible effects of N-acetylcysteine in autism spectrum disorders: major clinical aspects, eating behaviors, and sleeping habits." Turkish Journal of Pediatrics, 65, ss.832 - 844, 2023. 10.24953/turkjped.2022.573
ISNAD nalbant, kevser - ERDEN, SEMİH. "Possible effects of N-acetylcysteine in autism spectrum disorders: major clinical aspects, eating behaviors, and sleeping habits". Turkish Journal of Pediatrics 65/5 (2023), 832-844. https://doi.org/10.24953/turkjped.2022.573